靶点针对疾病信息21(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
Gamma-aminobutyric acid receptor (GAR)
INDICATI
Approved Anxiety disorder [ICD-11: 6B00-6B0Z]
INDICATI
Approved Ascariasis [ICD-11: 1F62]
INDICATI
Approved Bipolar disorder [ICD-11: 6A60]
INDICATI
approved Depression [ICD-11: 6A70-6A7Z]
INDICATI
Approved Enterobiasis [ICD-11: 1F65]
INDICATI
Approved Epilepsy/seizure [ICD-11: 8A61-8A6Z]
INDICATI
approved Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
INDICATI
approved Status epilepticus [ICD-11: 8A66]
INDICATI
Approved Tonus and reflex abnormality [ICD-11: MB47]
INDICATI
approved Tremor-related disorder [ICD-11: 8A04]
INDICATI
Phase 3 Obesity [ICD-11: 5B80-5B81]
INDICATI
Phase 2 Irritable bowel syndrome [ICD-11: DD91]
INDICATI
Phase 2 Metabolism inborn error [ICD-11: 5C50]
INDICATI
Discontinued in Phase 3 Female pelvic pain [ICD-11: GA34]
INDICATI
Terminated Substance abuse [ICD-11: 6C40]